Mouse Anti-Cytomegalovirus pp65-巨細(xì)胞病毒PP65抗體產(chǎn)品介紹：
Catalog Number : BYK-0271M
Quantity size : 0.1ml (1mg/ml dilute with Ph 7.4 0.01M PBS or antibody diluent)
Background: Cytomegalovirus is a member of the herpes virus group, which includes herpes simplex virus types 1 and 2, varicella zoster virus (which causes chicken pox), and Epstein Barr virus (which causes infectious mononucleosis). These viruses share a characteristic ability to remain dormant within the body over a long period. CMV viral genes are co-ordinay expressed in groups at various times after infection. Early viral proteins are expressed in the nucleus of infected cells within 3 to 24 hours of infection prior to the commencement of viral DNA replication. This is followed by expression of the early intermediate genes, which encode enzymes required for viral DNA replication. After 48 to 72 hours, a number of late viral antigens may be demonstrated in the nuclei and cytoplasm of infected cells. pp65 is a 65kD phosphorylated glycoprotein and is the most abundant of the late antigens.
Mouse Anti-Cytomegalovirus pp65-巨細(xì)胞病毒PP65抗體產(chǎn)品詳細(xì)資料
Specificity :
Anti-Cytomegalovirus pp65 is a mouse monoclonal antibody unconjugated
specific for Cytomegalovirus pp65 of Human, HCMVPP65
use for western blotting,elisa,immunoprecipitation and immunohistochemistry
Protein G affinity chromatography purification, purity :>95%
Isotype: IgG
mol wt: 65kDa
介紹：
Application :
Western blotting=1:100-500
ELISA=1:500-1000
Immunohistochemistry =1:100-500
Optimal working dilutions must be determined by the end user.
Storage: Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody, the antibody is stable for at least six weeks at 2-4 ℃
Important Note: This product as supplied is intended for research use only, not for use in human,therapeutic or diagnostic applications.
